JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, S.
Right arrow Articles by Kim, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, S.
Right arrow Articles by Kim, H. S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL

Vol. 280, Issue 1, 38-45, 1997

Modulation of ATP-Sensitive and Large-Conductance Ca++-Activated K+ Channels by Zeneca ZD6169 in Guinea Pig Bladder Smooth Muscle Cells

Shiling Hu and Helen S. Kim

Research Department, Pharmaceuticals Division, Ciba-Geigy Corp., Summit, New Jersey


    Abstract
Top
Abstract
Introduction
Methods
Results
Discussion
References

ZD6169, the S-enantiomer of the racemic N-(4-benzoylphenyl)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamide, was reported to possess a mechanoinhibitory effect on bladder detrusor smooth muscle through its ability to activate the KATP-sensitive K+ channel (KATP). In this study, the effects of ZD6169 and its racemic mixture on the whole-cell KATP and large-conductance Ca++-activated K+ (BKCa) currents in isolated smooth muscle cells from guinea pig bladder detrusor were examined by the patch-clamp technique. ZD6169 produced a multiple stimulatory and inhibitory effect on the KATP current. With a threshold effective concentration of 0.5 µM, it produced a glyburide-sensitive activation that reached a maximum between 5 and 10 µM. ZD6169 at concentrations greater than 20 µM markedly inhibited KATP channel, which resulted in a bell-shaped concentration-response relationship. Over a similar concentration range, ZD6169 caused a sizable stimulation of the BKCa current. All effects were readily reversible. Consistent with the data in whole-cell recordings, ZD6169 activated single BKCa channel in inside-out patches by increasing its open-state probability. Several lines of evidence showed that the opening of BKCa channel was Ca++ independent. The activity profile of the racemic ZD6169 on KATP and BKCa channels had remarkable resemblance to that of ZD6169. Our results indicate that ZD6169 exerts diverse effects on multiple types of K+ channels. A combination of the absence of KATP channel activation and the presence of BKCa channel stimulation by ZD6169 at higher concentrations may be responsible, in part, for its reported weaker cardiovascular side effects than cromakalim.


    Introduction
Top
Abstract
Introduction
Methods
Results
Discussion
References

ZD6169, the S-enantiomer of the racemic compound N-(4-benzoylphenyl)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamide recently discovered by Zeneca Pharmaceuticals Group (fig. 1), was reported to reduce the spontaneous mechanical activity in isolated guinea pig bladder detrusor (Li et al., 1995) and to inhibit contraction of normal and unstable bladder in rat and dog (Howe et al., 1995). These actions are considered potentially beneficial for the treatment of urinary urge incontinence, which is closely associated with instability or hyperreflexia of bladder detrusor smooth muscle. The results from electrophysiological and several functional studies demonstrated that ZD6169 selectively opened the KATP channels in smooth muscle cells, which led to membrane hyperpolarization and inhibition of the contractile force of the bladder muscle (Li et al., 1995; Trivedi et al., 1995b).


View larger version (8K):
[in this window]
[in a new window]
 
Fig. 1.   Chemical structure of ZD6169 (S-enantiomer) and racemic ZD6169.

Multiple types of K+ channel, including KATP, KV and BKCa channels, are present in bladder detrusor cells (Klockner and Isenberg, 1985; Bonev and Nelson, 1993; Trivedi et al., 1995a; Heppner and Nelson, 1995). The BKCa channel in spontaneously active bladder detrusor, unlike in many other types of vascular and nonvascular smooth muscle tissue, plays a predominant role in modulation of membrane excitability and myogenic contractility. As evidence of this notion, several reports showed that the application of BKCa channel blockers like chTX, ibTX and tetraethylammonium (TEA) drastically augmented the basal as well as stimulated contractile activity (Suarez-Kurtz et al., 1991; Zografos et al., 1992; Shetty et al., unpublished data). Relative to the BKCa channel, KATP channel in bladder detrusor contributes little to the muscle excitability, because glyburide, a specific KATP channel blocker, modifies neither the spontaneous myogenic activity nor 86Rb efflux in the absence of KATP channel openers (Zografos et al., 1992; Shetty et al., unpublished data). In light of the unique regulatory role of BKCa channel in bladder function in combination with the reported in vivo bladder selectivity of ZD6169 compared with cromakalim (Howe et al., 1995), it is speculative that ZD6169 may also interact with BKCa channel. To this end, the present study attempted to establish a profile of the electrophysiological actions of ZD6169 and its racemic compound on individual components of KATP and BKCa currents in freshly isolated guinea pig detrusor muscle cells. The results revealed a complex mode of action of this compound on KATP channel and a direct opening activity on the BKCa channel. ZD6169 thus appears to be a dual K+ channel opener.

    Methods
Top
Abstract
Introduction
Methods
Results
Discussion
References

Cell isolation. Male guinea pigs (~300 g) were sacrificed by exposure to CO2 for 2 min. The urinary bladder was removed and rinsed in a Ca++-free medium composed of 135 mM NaCl, 5.4 mM KCl, 2 mM MgSO4, 5 mM glucose, 10 mM HEPES and pH 7.3 adjusted with NaOH. The detrusor muscle was cut and cleaned free of connective tissue and blood vessels. Pieces of tissue were then incubated for two periods of 35 min at 36°C in an enzyme medium containing 130 mM K glutamate, 20 mM taurine, 5 mM pyruvate, 5 mM creatine, 10 mM HEPES and 0.5 mM CaCl2 complemented with 1 mg/ml collagenase (Sigma, C2139), 0.2 mg/ml pronase (Sigma, P5147), 1 mg/ml fatty acid-free albumin. During incubation, tissue pieces were gently stirred to assure a full exposure to the enzymes. After a total of 70 min enzyme digestion, single bladder smooth muscle cells were obtained by gentle agitation of the preparation through a Pasteur pipette into the "KB" solution (Isenberg and Klockner, 1982). Single cells were stored at 4°C for 1 h before recording.

Experimental setting and current recording. Experiments were performed at 22°C with the whole-cell or inside-out configurations of the patch-clamp technique (Hamill et al., 1981) in enzymatically dispersed smooth muscle cells from guinea pig bladder detrusor. Patch electrodes were pulled from Kimax-51 capillary tubes (Kimble Products, Vineland, NJ). The resistance of electrodes after fire polishing was around 2 megohm for the whole-cell mode to increase the rate of solution dialysis and around 5 megohm for the inside-out mode to reduce the number of channels recorded. Whole-cell currents were amplified by a List EPC-7 amplifier (Adams & List Assoc., Darmstadt, Germany), digitized at 4 kHz with a TL-1-125 DMA interface (Axon Instruments) and stored on a Compaq DeskPro/66 M microcomputer for later analysis with pClamp version 6.03 (Axon Instruments, Foster City, CA). The inside-out single-channel recordings were first low-pass-filtered at 2 kHz by an 8-poles Bessel filter (Frequency Devices 902LPF) and video-taped with a Toshiba Pulse-Code Modulation data recorder (DX-900). After each experiment, the recordings were played back through a window discriminator (AI2020, Axon Instruments) at a sampling rate of 4 kHz and stored on the computer for analysis. The junction potential between the electrodes and the bath solution was compensated by the DC offset on the amplifier. No leak subtraction was applied. The cell capacitance was 34.8 ± 2.5 pF (n = 16).

Two distinct voltage-clamp protocols, a ramp and a step, were used for the whole-cell recordings. The ramp experiments were designed to study the effect of ZD6169 on the KATP current. Cells were clamped at -50 mV and a voltage ramp ranging between -110 mV and +30 mV or between -110 mV and +110 mV with a duration of 1.5 s was applied. The bath solution was composed of 140 mM KCl, 5 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 10 mM HEPES and 5 mM glucose; and the pipette solution had 140 mM KCl, 1 mM MgCl2, 0.1 mM CaCl2, 0.6 mM EGTA, 2 mM Na2UDP, 0.5 mM K2ATP, 5 mM glucose and 10 mM HEPES, in which the free Ca++ concentration was estimated to be 10-8 M (Imai and Takeda, 1967). The step voltage-clamp experiments were used to study the effect of ZD6169 on the BKCa current. Cells were subjected to depolarization steps from -30 to +75 mV in a 15-mV increment from a holding potential of 0 mV. The bath solution contained 140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 10 mM HEPES and 5 mM glucose; and the pipette solution was basically same as in the ramp experiments except that the concentration of K2ATP was increased to 2 mM, with which the time-independent KATP current was presumably inactivated. In inside-out single-channel recordings, the pipette and the bath solutions had the same composition of 140 mM KCl, 5 mM NaCl, 1 mM MgCl2, 10 mM HEPES and 5 mM glucose; except for the CaCl2 concentration, which was 10-3 M in the pipette and 10-8 M in the bath buffered with EGTA.

ZD6169 and its racemic compound were synthesized in the Research Department of Ciba-Geigy Corp. The drugs were first dissolved in 95% ethyl alcohol to form a stock solution of 50 mM, which was then diluted with saline to the desired concentrations shortly before experiments. In this study, vehicle control experiments were performed and showed that ethyl alcohol at a maximal concentration of 0.1% had no discernible electrophysiological effects on K+ channels.

    Results
Top
Abstract
Introduction
Methods
Results
Discussion
References

Concentration-dependent dual effect of ZD6169 on KATP current. The effect of ZD6169 on the KATP current was investigated when cells were bathed in symmetrical K+ (140 mM) solutions to increase inward current and clamped at -50 mV to minimize activation of other voltage-dependent K+ currents at negative membrane potentials. Current was elicited by a ramp protocol ranging from -110 mV to +110 mV over a period of 1.5 s. With only 0.5 mM ATP in the pipette solution, the steady-state holding current was presumably composed of leakage current and a basal activity of KATP channels. In the absence of ZD6169, small inward current, basically KATP channel in isolation, was detected at potentials negative to 0 mV (fig. 2A). To better display the modification of inward KATP current by the drug, a high-current magnification was used in figure 2, in which the sizable outward rectifying current at the positive voltages was largely out of scale. The inward KATP current was increased by ZD6169 at 0.5 µM (fig. 2B) and 5 µM (fig. 2C) in a concentration-dependent manner. As the concentration of ZD6169 further increased to 50 µM, the stimulatory effect on the KATP current diminished and a significant inhibitory effect manifested instead (fig. 2D). This dual effect on the KATP channel was observed in 10 of 12 cells studied. Additional studies in which the concentration increment was made smaller showed that a maximal activation of KATP channel by ZD6169 occurred between 5 and 10 µM, depending on individual cell. The effects on KATP channel were fully reversible upon washout of ZD6169 (fig. 2E). The current activated by ZD6169 (5 µM) was completely prevented (fig. 3, A-C) and reversed (fig. 3, A, C and D) by 1 µM glyburide, a specific KATP channel blocker, which indicated that ZD6169-activated current was, by nature, the KATP current.


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 2.   Concentration-dependent dual action of ZD6169 on KATP channel. These recordings are representative of the whole-cell currents in response to a 1.5-s voltage ramp from -110 to +110 mV (as shown at the top) in control (A), in the presence of ZD6169 at 0.5 µM (B), 5 µM (C) and 50 µM (D), and after washout of the drug (E). The cell was bathed in symmetrical 140 mM K+ solutions and held at -50 mV. Calcium concentration was 10-3 and 10-8 M in bath and pipette solution, respectively. The pipette solution contained 0.5 mM ATP to facilitate the activation of KATP channels. A high magnification is used to better display the changes in the inward KATP current, whereas a large portion of current at positive potential, rectifying outwardly, is out of scale. Dashed lines indicate the zero current level. The scale of a 0.5 nA reference current is shown at the lower left corner.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 3.   ZD6169-activated current is sensitive to glyburide. Whole-cell currents were elicited in response to a 1.5-s voltage ramp from -110 mV to +30 mV (as shown at the top) in control (A), in 5 µM ZD6169 with 1 µM glyburide (B), in 5 µM ZD6169 alone (C) and again in 5 µM ZD6169 and 1 µM glyburide (D). The cell was bathed in symmetrical 140 mM K+ solution and held at -50 mV. The pipette solution contained 0.5 mM ATP. Dashed lines indicate the zero current level. The scale of a 0.5 nA reference current is shown at the lower left corner.

Activation of BKCa current by ZD6169. The effect of ZD6169 on the BKCa current was investigated when cells were bathed in physiological solutions ([K+]i 140 mM/[K+]o 5 mM) and clamped at 0 mV to inactivate other voltage-dependent K+ currents, allowing the demonstration of BKCa channel alone in response to a series of voltage steps (Olesen et al., 1994). The pipette solution contained 2 mM ATP, a concentration considerably higher than 40 to 50 µM, the concentration generally found to half-maximally inhibit the KATP channel. Voltage steps ranging between -30 mV and +75 mV with an increment of 15 mV from a holding potential of 0 mV elicited a family of noisy, time-dependent and noninactivating currents (fig. 4, A and D), of which more than 85% were blockable by 2 mM TEA (fig. 4, B and C) and 80 nM ibTX (fig. 4, E and F), which indicated a predominant contribution of the BKCa channel to the current. Figure 5 shows the effects of ZD6169 at concentrations of 0.5, 5 and 50 µM on the whole-cell BKCa currents in a typical experiment. In 13 of 14 cells tested, significant activation of the BKCa currents by ZD6169 was observed only at concentrations equal to or higher than 20 µM (fig. 5D). However, in 4 of 13 responsive cells ZD6169 caused a dose-dependent augmentation of the BKCa currents at concentrations ranging between 0.5 and 50 µM. The BKCa channel-activating effect had a rapid onset and offset, and was fully reversible within 1 to 2 min (fig. 5E).


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 4.   Whole-cell BKCa currents are sensitive to TEA and ibTX. A family of whole-cell BKCa currents were elicited by a voltage-step protocol ranging from -30 mV to +75 mV with an increment of 15 mV from a holding potential of 0 mV in control (A), in 2 mM TEA (B) and the current-voltage relationship of A (circles) and B (squares). Data in A, B and C were obtained from the same cell. Results of a parallel experiment from another cell in control (D), in 80 nM ibTX (E) and the current-voltage curves for D (triangles) and E (diamonds). The voltage-step protocol had a duration of 1 s. The cell was bathed in physiological K+ solutions ([K+]i 140 mM/[K+]o 5 mM). The pipette solution contained 2 mM ATP.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 5.   ZD6169 activates BKCa current. Whole-cell currents were elicited by a voltage-step protocol ranging from -30 mV to +75 mV with an increment of 15 mV and a duration of 1 s (as shown at the top) in control (A), during subsequent exposure to ZD6169 at 0.5 (B), 5 (C) and 50 µM (D), and after washout of the drug (E). A holding potential of 0 mV was used to inactivate other voltage-dependent K+ currents. The cell was bathed in physiological K+ solutions ([K+]i 140 mM/[K+]o 5 mM). The pipette solution contained 2 mM ATP. The scale of a 5 nA reference current is shown at the lower left corner.

Voltage dependence of the effects of ZD6169. The instantaneous current-voltage relationship in the absence and presence of ZD6169 was assessed in a conventional way by use of the ramp protocol used in figure 2; the results are shown in figure 6. The KATP current (most visible in the inward direction) underwent a reversible stimulation and a suppression as the concentration increased (fig. 6, A-E). The current at potentials positive to 0 mV, rectifying in an outward direction, was largely composed of the current through the BKCa channels. A reversible augmentation of this current component by ZD6169 at 50 µM is readily visible in figure 6D. Figure 6F illustrates the overall effects of ZD6169 on KATP and BKCa currents. The increase (from the control) in the amplitude of the maximum inward KATP current measured at -110 mV in the ramp experiments was 15.0 ± 6.3%, 52.1 ± 12.7% and -29.6 ± 4.1% (n = 12); whereas the increase (from the control) of the BKCa current at +60 mV in the step experiments was 10.0 ± 2.3%, 15.2 ± 3.2% and 47.5 ± 3.3% (n = 14), respectively, in the presence of 0.5, 5 and 50 µM of ZD6169.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of ZD6169 on current-voltage relationship. Whole-cell currents were recorded with a voltage ramp ranging from -110 mV to +110 mV over a period of 1.5 s (as shown at the top) in control (A), in ZD6169 at 0.5 µM (B), 5 µM (C) and 50 µM (D), and after washout of the drug (E). The holding potential was -50 mV. The cell was bathed in symmetrical 140 mM K+ solutions. The pipette solution contained 0.5 mM ATP. Dashed lines indicate the zero current level. The scale of a 2 nA reference current is shown at the lower left corner. Panel F illustrates the changes (from the control) in the maximum inward KATP current measured at -110 mV in the ramp voltage-clamp experiments (hatched bars) and in the BKCa current measured at +60 mV in step voltage-clamp experiments (filled bars) induced by ZD6169 at 0.5, 5 and 50 µM. The abscissa gives the concentration of ZD6169 (µM), and the ordinate denotes changes of the current, which were calculated according to the formula: % change = (IK in ZD6169 - IK in control)/(IK in control).

Activation of BKCa by ZD6169 (50 µM) is independent of Ca++. The results in figure 6F demonstrated that ZD6169 at 50 µM caused simultaneously an inhibition of the KATP current and an activation of the BKCa current. The former effect would presumably lead to membrane depolarization followed by the opening of the voltage-dependent Ca++ channels. It was therefore speculated that the stimulation of the BKCa channel might be secondary to the inhibition of KATP channels via an increase in intracellular free Ca++. We investigated whether Ca++ signaling bridged these two events by scrutinizing the Ca++ dependence of ZD6169-induced BKCa channel activation. It was found that ZD6169 stimulated the whole-cell BKCa current by a similar magnitude in the presence and absence of Ca++ in the bath (data not shown), which indicated that the effect is independent of extracellular Ca++ concentration. The effect was also unaffected by the addition of up to 12 µM nifedipine, a Ca++ channel blocker, to the bath. Figure 7 shows the effect of 50 µM ZD6169 on the whole-cell BKCa currents elicited by depolarization steps in the absence (fig. 7, A-C) and in the presence (fig. 7, D-F) of 1 µM nifedipine. Apparently, the activation of the BKCa currents by ZD6169 persisted regardless of blockade of the voltage-dependent Ca++ influx. Thus, the effect was independent of the change in [Ca++]i resulting from Ca++ influx.


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of ZD6169 on BKCa currents is independent of Ca++ influx. Whole-cell BKCa currents were augmented by 50 µM ZD6169 in the absence (A, B and C) and presence of 1 µM nifedipine (D, E and F). Currents were elicited by a voltage-step protocol ranging from -30 mV to +75 mV with an increment of 15 mV from a holding potential of 0 mV (as shown at the top). The bath and pipette solutions contained, respectively, 10-3 and 10-8 M Ca++. The BKCa currents in control (A) were activated during exposure to 50 µM ZD6169 (B), and reversed upon washout of ZD6169 (C). Current recordings of a parallel experiment but in the presence of 1 µM nifedipine throughout were made in another cell (D, E and F). The ordinates in A and D indicate the current scales. The scales in B and C are the same as in A, and those in E and F are the same as in D.

To further assess the possibility that BKCa channel activation may be triggered by an increase in [Ca++]i subsequent to Ca++ release from intracellular store, we examined the effect of ZD6169 on single BKCa channels in inside-out cell-detached patches, in which the intracellular organelles were absent and [Ca++]i was clamped by EGTA at a constant level of 10-8 or 10-9 M. The BKCa channel in guinea pig detrusor muscle cells had a conductance of 208.5 ± 5.9 pS (n = 23) in symmetrical 140 mM K+ solutions. Its activity was highly dependent on [Ca++]i and membrane potential. The relationship between the channel open-state probability (NPo) and voltage (V) followed a Boltzmann distribution (Hu et al., 1989), which shifted toward more negative voltage by 11 mV when [Ca++]i was increased from 10-9 to 10-8 M. With such a change in [Ca++]i, the voltage sensitivity of the channel remained unchanged. An e-fold increase in NPo took place with a 10.2-mV membrane depolarization, a value well within the range of the voltage sensitivities of the Ca++-activated K+ channels in a variety of cell types (Marty, 1983; Singer and Walsh, 1987). As [Ca++]i was raised to 10-7 M, the channel became so active that it virtually maintained a steady open state at all voltages tested. Figure 8 shows typical single-channel recordings in the absence and presence of ZD6169 at concentrations of 0.5, 5 and 50 µM as [Ca++]i was made at 10-8 M. When ZD6169 was applied in the bath of inside-out patches (intracellular side), it did not affect the single-channel conductance but increased NPo of BKCa channel by 41.5 ± 20.5%, 56.2 ± 5.5% and 297.7 ± 117.2% (n = 6), respectively. Parallel experiments were performed when [Ca++]i was clamped at 10-9 M, in which ZD6169 at 0.5, 5 and 50 µM caused, respectively, an increase in NPo by 11.8 ± 6.2%, 151.3 ± 23.7% and 238.9 ± 95.5% (n = 4). Because of the overly high basal activity of the channel at [Ca++]i of 10-7 M, a quantitative assessment of changes in channel activity induced by ZD6169 was not possible. In summary, the single-channel experiments demonstrated 1) ZD6169 activated the BKCa channel as [Ca++]i was kept constant; 2) the magnitude of activation did not apparently correlate with [Ca++]i.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 8.   ZD6169 activates single BKCa channels in an inside-out patch. Representative single BKCa recordings (from top to bottom) in control, in the presence of ZD6169 at 0.5, 5 and 50 µM, and after washout of the drug. Recordings were made from an inside-out patch held at +50 mV and exposed to symmetrical K+ (140 mM) solutions with a free Ca++ concentration of 10-8 M in bath solution. In all panels, two current traces are consecutive recordings with a total duration of 20 s. Upward deflections are the opening events of the channel, whose closed state is indicated by the short lines at the left of the traces. Currents were filtered at 2 kHz.

Effects of racemic ZD6169 on KATP and BKCa channels. ZD6169 was reported to display a stereoselectivity. Being the active S-enantiomer, ZD6169 is about 30-fold more potent than the R-enantiomer in mechanoinhibitory activity (Li et al., 1995). The racemic ZD6169 was tested in experiments parallel with those with ZD6169. Analogous to the experiment with ZD6169 (S-enantiomer) in figure 2, figure 9 shows a typical concentration-dependent dual effect of the racemic ZD6169 on inward KATP current evoked by a voltage ramp. Likewise, the opening effect on the BKCa current elicited by a step voltage protocol is demonstrated in figure 10. It is obvious that the effects of the racemic ZD6169 on the KATP and the BKCa currents were not dissimilar to those of ZD6169. All effects were readily reversible.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 9.   Concentration-related dual action of racemic ZD6169 on KATP current. These recordings are representative of the whole-cell current in response to a 1.5-sec voltage ramp from -110 to +30 mV (as shown at the top) in control (A), in the presence of ZD6169 at 0.5 µM (B), 5 µM (C) and 50 µM (D). The cell was bathed in symmetrical 140 mM K+ solutions and held at -50 mV. Calcium concentration was 10-3 and 10-8 M in bath and pipette solution, respectively. The pipette solution contained 0.5 mM ATP. Dashed lines indicate the zero current level. A 0.5 nA reference current is shown at bottom left of the figure.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 10.   Racemic ZD6169 activates BKCa current. Whole-cell currents were elicited by a voltage-step protocol ranging from -30 mV to +75 mV with an increment of 15 mV and a duration of 1 s (as shown at the top) in control (A), during subsequent exposure to ZD6169 at 0.5 (B), 5 (C), and 50 µM (D), and after washout of the drug (E). The holding potential was 0 mV. The cell was bathed in physiological K+ solutions ([K+]i 140 mM/[K+]o 5 mM). The pipette solution contained 2 mM ATP. A 2 nA reference current is shown at lower left corner.

    Discussion
Top
Abstract
Introduction
Methods
Results
Discussion
References

Zeneca ZD6169, an anilide tertiary carbinol, represents a new structural class of K+ channel openers and is currently under the development by Zeneca Pharmaceuticals Group as an intervention therapy for urinary urge incontinence. As a bladder smooth muscle relaxant agent, its mechanism of action has recently been investigated. Results from several functional and electrophysiological assays provided evidence showing that ZD6169 exerts its mechanoinhibitory action in bladder detrusor by opening the KATP channels (Li et al., 1995; Trivedi et al., 1995b). The present study has shown that the pharmacology of ZD6169 is more complex than originally described, and the drug possesses multiple excitatory and inhibitory effects on multiple types of K+ channel.

In this study, the KATP current was measured with voltage ramp protocols at voltages negative to 0 mV after optimizing the conditions for the detection of the current. Cells were bathed in symmetrical K+ (140 mM) solutions to increase inward current and clamped at -50 mV to minimize activation of other voltage-dependent K+ currents (Clapp et al., 1994). The intracellular ATP concentration was reduced to 0.5 mM to facilitate the activation of the KATP channel. At voltages negative to 0 mV where BKCa channel and delayed rectifier K+ current were minimal, the inward KATP current was visibly detected (figs. 2 and 3). After the application of ZD6169 at lower concentrations (0.5-10 µM, fig. 2), significant inward current was activated in a concentration-dependent manner. The activated current had little voltage dependence and was completely abolished by 1 µM glyburide (fig. 3), which indicated that ZD6169 acted to open the KATP channel. Our observation is consistent with the electrophysiological data reported by Li et al. (1995). They showed that 10 µM ZD6169 induced a sustained increase in whole-cell KATP current. A novel and unexpected finding was the significant inhibition of KATP current by ZD6169 at concentrations higher than 20 µM. The mechanism(s) underlying the transition from a stimulatory to an inhibitory action is not clear at the present time and will be the subject of future study. Collectively, the concentration-response curve of the effects of ZD6169 on the KATP current had a bell shape with a maximum activation reached at a concentration of approximately 10 µM.

The chTX- and ibTX-sensitive BKCa channel has been reported to play a predominant role in controlling cell excitability and contractility in guinea pig bladder muscle (Suarez-Kurtz et al., 1991; Zografos et al., 1992; Shetty et al., unpublished data). Although the presence of the BKCa channel in guinea pig bladder smooth muscle cells was explored earlier (Klockner and Isenberg, 1985; Trivedi et al., 1995a), direct recording of the isolated BKCa current is however lacking. In the present study, the whole-cell BKCa current was demonstrated in isolation by use of voltage-step protocol with a holding potential of 0 mV, at which the other voltage-dependent K+ current was inactivated and by use of 2 mM ATP in the pipette solution to inhibit the KATP current (Olesen et al., 1994; Edwards et al., 1994). The single BKCa channel in guinea pig bladder cells was found to be highly dependent on membrane potential and intracellular Ca++ with a voltage and Ca++ sensitivity similar to those of the conventional BKCa channels in various types of cells (Marty, 1983; Singer and Walsh, 1987). The single-channel conductance of 209 pS in symmetrical K+ (140 mM) solutions was also in a good agreement with the conductances of typical BKCa channels in other tissues (Lattore et al., 1989). To our best knowledge, the BKCa currents at whole-cell as well as single-channel level in guinea pig bladder muscle cells, for the first time, were measured directly, and the effects of ZD6169 on the channels were assessed.

An important observation of the present study was that over a similar concentration range (>20 µM), ZD6169 not only inhibited the KATP current, but also significantly enhanced the BKCa current. This type of multiple inhibitory and stimulatory actions is not unique to ZD6169 but is also shared by reported BKCa channel openers NS004 (Xu et al., 1994; Hu et al., 1994) and NS1619 (Edwards et al., 1994). In theory, a closing of the KATP channel and an opening of the BKCa channel over a similar concentration range could be causally related, because the inhibition of KATP channel would lead to membrane depolarization, activation of Ca++ influx and hence stimulation of the BKCa channel. However, this sequence of events did not apply to the effects of ZD6169. We found that the augmentation of the whole-cell BKCa current by ZD6169 was unaffected by the removal of extracellular Ca++ or by the presence of Ca++ channel blocker, which suggested that the effect did not involve changes in [Ca++]o or [Ca++]i subsequent to Ca++ influx. In inside-out detached patches, ZD6169 was capable of opening the channel when the cytosolic Ca++ concentration was held constant. In addition, the magnitude of stimulation did not significantly differ whether [Ca++]i was 10-9 or 10-8 M. Thus, the effect was independent of the change in [Ca++]i. In settings like detached patches, in which the activities of intracellular biochemical or biophysical pathways are usually disrupted because of a lack of substrates or cellular organelles, a second messenger (e.g., IP3) mediated process for the effect of ZD6169 on the BKCa channel was most unlikely, although there was a report on the preservation of functional intracellular Ca++ store sites in detached patches of smooth muscle cells from rabbit portal vein (Xiong et al., 1992). It is therefore conceivable that the stimulatory effect of ZD6169 on the BKCa channel is a direct interaction between the drug and the channel gating, and the inhibition of KATP channel is not causally linked to the activation of BKCa channel through Ca++ signaling.

Based on the reported in vitro data that the mechanoinhibitory effect of ZD6169 was antagonized by glyburide (Li et al., 1995), an opening of the KATP channel is likely to be the primary mechanism of relaxant action. Our data in figure 6 showed that ZD6169 is capable of augmenting the BKCa channel with a magnitude comparable to the magnitude of the activation of the KATP channel. Considering the unique role of the BKCa channel in bladder muscle excitability, the ZD6169-induced the BKCa channel activation would also be an obligate mechanism underlying its bladder relaxant effect. Although glyburide was reported to cause a rightward shift of the concentration-response curve of ZD6169-induced relaxation of guinea pig detrusor strips (fig. 4; Li et al., 1995), the shift was not strictly parallel when the concentration of ZD6169 was 10 µM or greater. A possible explanation could be that the relaxation induced by ZD6169 at higher concentrations is not primarily caused by an opening of the KATP channel but of the BKCa channel.

The in vivo pharmacology of ZD6169 has recently been assessed in comparison with cromakalim, a reference KATP channel opener (Howe et al., 1995). The results showed that ZD6169 produced a bladder inhibitory profile similar to that of cromakalim, but a significantly weaker cardiovascular activity than cromakalim. It remains to be established whether this in vivo selectivity derives from pharmacokinetic factors or ZD6169 is able to exploit any possible difference between KATP channels in different tissues. Nevertheless, the diverse activities of ZD6169 on multiple types of K+ channels might, in part, be responsible for the in vivo selectivity. The diminished stimulatory effects on KATP channel as the drug concentration increases may contribute to the weaker effects on heart rate and blood pressure, whereas a simultaneous activation of BKCa channel may ameliorate the inhibitory effect on bladder because of the pivotal role of the BKCa channel (generally absent in cardiac tissues) in bladder contractility (Suarez-Kurtz et al., 1991; Zografos et al., 1992).

In summary, Zeneca ZD6169 exerts diverse actions on multiple types of K+ channels in smooth muscle cells from guinea pig bladder detrusor. Depending on the concentration, it produces a dual stimulatory and inhibitory effect on KATP channel and a stimulatory effect on the BKCa channel. An agent with such an electrophysiological profile may be potentially beneficial for the treatment of urinary urge incontinence with less undesired cardiovascular side effects.

    Acknowledgments

The authors thank Dr. Cynthia A. Fink for her effort in the synthesis of racemic and S-enantiomer of ZD6169, which made this study possible.

    Footnotes

Accepted for publication September 6, 1996.

Received for publication April 22, 1996.

Send reprint requests to: Dr. Shiling Hu, Rm. LSB 2287, Research Department, Pharmaceuticals Division, Ciba-Geigy Corp., 556 Morris Avenue, Summit, NJ 07901.

    Abbreviations

ZD6169, (S)-N-(4-benzoylphenyl)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamide; BKCa, large-conductance Ca++-activated K+ channel; KATP, ATP-sensitive K+ channel; KV, voltage-dependent K+ channel; chTX, charybdotoxin; ibTX, iberiotoxin; HEPES, N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid; EGTA, ethyleneglycol-bis(beta -aminoethyl ether)-N,N,N',N'-tetraacetic acid.

    References
Top
Abstract
Introduction
Methods
Results
Discussion
References


0022-3565/97/2801-0038$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
A. Sculptoreanu, N. Yoshimura, and W. C. de Groat
KW-7158 [(2S)-(+)-3,3,3-Trifluoro-2-hydroxy-2-methyl-N-(5,5,10-trioxo-4,10-dihydrothieno[3,2-c][1]benzothiepin-9-yl)propanamide] Enhances A-Type K+ Currents in Neurons of the Dorsal Root Ganglion of the Adult Rat
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 159 - 168.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Wojdan, C. Freeden, M. Woods, G. Oshiro, W. Spinelli, T. J. Colatsky, J. H. Sheldon, N. W. Norton, D. Warga, M. M. Antane, et al.
Comparison of the Potassium Channel Openers, WAY-133537, ZD6169, and Celikalim on Isolated Bladder Tissue and In Vivo Bladder Instability in Rat
J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1410 - 1418.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, S.
Right arrow Articles by Kim, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, S.
Right arrow Articles by Kim, H. S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition